There are 2949 resources available
88MO - T-cell responses induced by an individualized neoantigen specific immune therapy in post (neo)adjuvant patients with triple negative breast cancer
Presenter: Marcus Schmidt
Session: Mini Oral - Translational research
Resources:
Abstract
Slides
Webcast
1931MO - A HER3/DUSP6 loop determines sensitivity to HER2-targeted therapies in breast cancer
Presenter: Majid Momeny
Session: Mini Oral - Translational research
Resources:
Abstract
Slides
Webcast
1932MO - Ki67 expression and CDK4/6i activity: An emerging role for PIK3CA mutations in metastatic breast cancer patients
Presenter: Marzia Del Re
Session: Mini Oral - Translational research
Resources:
Abstract
Slides
Webcast
1933MO - TransFAL: Establishment of clinical trial-matched luminal breast cancer patient-derived xenografts (PDX) for translational studies
Presenter: Marta Palafox
Session: Mini Oral - Translational research
Resources:
Abstract
Slides
Webcast
1675MO - Screening of COVID-19 disease based on chest CT and PCR for cancer patients undergoing radiotherapy in a French coronavirus hotspot
Presenter: Roger Sun
Session: Mini Oral - SARS-CoV-2 and cancer 2
Resources:
Abstract
Slides
Webcast
1676MO - Prevalence and clinical impact of asymptomatic or mildly symptomatic SARSCoV-2 infection among actively treated cancer patients during COVID-19 pandemic in Italy
Presenter: Alberto Zambelli
Session: Mini Oral - SARS-CoV-2 and cancer 2
Resources:
Abstract
Slides
Webcast
LBA83 - Outcomes of the 2019 novel coronavirus in patients with or without a history of cancer: A multi-centre North London experience
Presenter: Nalinie Nalinie Joharatnam-Hogan
Session: Mini Oral - SARS-CoV-2 and cancer 2
Resources:
Abstract
Slides
Webcast
1677MO - COVID-19 mortality in hospitalized cancer patients is not significantly affected by chemotherapy or other anti-cancer treatments
Presenter: Lennard Lee
Session: Mini Oral - SARS-CoV-2 and cancer 2
Resources:
Abstract
Slides
Webcast
LBA81 - Keeping exhausted T-cells in check in COVID-19
Presenter: Pierre Van Mol
Session: Mini Oral - SARS-CoV-2 and cancer 2
Resources:
Abstract
Slides
Webcast
LBA82 - Influenza-like illness and SARS-Cov-2 in the multicenter, prospective, observational INVIDIa-2 study (INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: A transversal challenge): A FICOG study
Presenter: Melissa Bersanelli
Session: Mini Oral - SARS-CoV-2 and cancer 2
Resources:
Abstract
Slides
Webcast